Hims & Hers Health Investors Have Opportunity to Join Securities Fraud Lawsuit
Rosen Law Firm is inviting investors in Hims & Hers Health securities to participate in a class action lawsuit alleging securities fraud. Investors have a November 2 deadline to act as lead plaintiff.
New York, NY – October 12, 2026 – The Rosen Law Firm, a global investor rights law firm, has announced that purchasers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025, and July 29, 2026, inclusive, have the opportunity to participate in a class action lawsuit. The lawsuit alleges securities fraud, and a crucial deadline for potential lead plaintiffs is November 2, 2026.
According to the lawsuit, Hims & Hers is accused of sharing consumer health information with third-party advertising platforms. The complaint also alleges that the company charged consumers for prescriptions almost immediately after they submitted an intake form, contrary to assurances that users could consult with a medical provider to find the "right" treatment. These alleged actions have reportedly subjected the company to regulatory scrutiny and potential fines.
Rosen Law Firm is seeking investors who purchased Hims & Hers securities during the specified period to come forward for information regarding the class action. The firm states it will handle the case on a contingency fee basis, meaning investors would not incur out-of-pocket costs. The firm emphasizes its experience in securities class actions.
No class has yet been certified in the matter. Investors are not currently represented by counsel unless they retain their own. They may choose to remain an absent class member. An investor's ability to share in any potential recovery is not dependent on serving as lead plaintiff.